TY  - JOUR
AU  - Carmona, MDolores
AU  - Paco-Meza, Luis-Miguel
AU  - Ortega, Rosa
AU  - Cañadillas, Sagrario
AU  - Caballero-Villarraso, Javier
AU  - Blanco, Alfonso
AU  - Herrera, Concha
PY  - 2021
DO  - 10.1016/j.prp.2021.153756
UR  - http://hdl.handle.net/10668/22479
T2  - Pathology, research and practice
AB  - Mesenchymal stromal cells (MSC) have demonstrated ability to improve diabetic nephropathy (DN) in experimental models, as well as by improving kidney endogenous progenitor cells proliferation and differentiation. Many studies have demonstrated the...
LA  - en
PB  - Elsevier
KW  - ASC dysfunction
KW  - Adipose-derived mesenchymal stromal cells
KW  - Diabetic nephropathy
KW  - Hypoxia preconditioning
KW  - Regenerative therapy
KW  - Renal injury
KW  - Adipose tissue
KW  - Albuminuria
KW  - Animals
KW  - Blood glucose
KW  - Cell hypoxia
KW  - Cell proliferation
KW  - Cells, cultured
KW  - Creatinine
KW  - Diabetes mellitus, experimental
KW  - Diabetic nephropathies
KW  - Fibrosis
KW  - Kidney
KW  - Male
KW  - Mesenchymal stem cell transplantation
KW  - Mesenchymal stem cells
KW  - Rats, Wistar
KW  - Streptozocin
KW  - Urea
TI  - Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
TY  - research article
VL  - 230
ER  -